Anduril in Talks to Sell Insider Shares at Roughly $90 Billion Valuation

The story so far

2 publishers have covered this in 2 articles since 14 Oct 2026. Bloomberg.com published first, on 14 October at 17:11 UTC; Quartz followed 19 min later. The most recent article, from Quartz, appeared on 14 October at 17:30 UTC.

Outlets reporting it: Bloomberg.com (major outlet), Quartz.

3 prediction markets price this story:

• Anduril — the market puts it at 21%, with $23 traded in the last 24 hours, closing 1 Jan 2027. The outcome is Yes if any part of the U.S. federal government takes a stake in Anduril before January 1, 2027. The outcome is No if this event does not occur by that date. Readers often mistake the linked news story about Lux Capital for the official resolution source.
• Anduril — the market puts it at 1%, closing 1 Jan 2027. The outcome is Yes if Anduril confirms an initial public offering before January 1, 2027. The outcome is No if no such confirmation occurs by that date. Readers often mistake the linked news story about share sales for a confirmation of an IPO.
• Before Jun 1, 2027 — the market puts it at 21%, with $1 traded in the last 24 hours, closing 1 Jun 2027. The market resolves to Yes if Anduril confirms an initial public offering before June 1, 2027. It resolves to No if that confirmation does not happen by that date. Readers often mistake news of valuation talks or private share sales for a confirmed IPO.

Odds are the market's probability that the outcome happens, updated every few minutes. They are information about what traders expect, not a forecast we make and not investment advice.